Accentus Medical, a leading developer of advanced surface modifications and coating technologies, is delighted to announce its success in winning the Best New UK Medtech Development Programme in the OBN 2015 Awards.
The winners in each of twelve award categories were announced at the OBN Annual Awards Dinner on Thursday 1 October 2015, held at the Ashmolean Museum, Oxford. The event was attended by senior executives and influential players from the most innovative and dynamic biotech and medtech companies in the OBN network.
The OBN judging panel of high profile global investors commented on the elegant solution that Agluna® provides to the massive problem of post-operative infection, and the massive difference the technology looks set to make to the need for revision surgery. They also noted that Agluna® is well developed and cost effective, and that Accentus Medical is attracting increased recognition for its achievements so far.
Dr Philip Agg, CEO, said: “We are delighted to win this prestigious OBN award in the category of Best New UK Medtech Development Programme. The award comes at a time when the company is building momentum in developing and commercialising our Agluna® technology within several implantable medical device sectors. We are looking forward to continuing our endeavours to bring the technology into widespread clinical use, to the benefit of patients and clinicians across global healthcare markets.”
-ends-
For further information, please contact:
Philip Agg, CEO
T: +44 (0)1235 434328
Email: enquiries@accentus-medical.com
About OBN
OBN is the membership organisation supporting and bringing together the UK’s emerging life sciences companies, corporate partners and investors. The OBN Annual Awards celebrate outstanding achievements within the UK life sciences sector over the preceding year.